Fmotorblock(min) Firstanalgesicrequest(min) Shivering(n) Nausea(n) Vomiting(n) Pruritus
Fmotorblock(min) Firstanalgesicrequest(min) Shivering(n) Nausea(n) Vomiting(n) Pruritus(n) Group C (n=21) Group Mg (n=20) pRESULTS One particular patient in Group C was excluded because of inaccurate magnesium measurements as a consequence of haemolysis in their bloodsample.TwopatientsinGroupMgwereexcludeddue to blood-stained CSF sampling. Surgical anaesthesia was accomplished in all sufferers without any intraoperative analgesic requirement. Demographic information, gestational weeks, serum and CSFmagnesiumlevelsaregiveninTable1.Nostatisticaldifference was noted among the groups in terms of patients’ demographics and gestational weeks. Mean duration of MgSO4 infusion in pre-eclamptic individuals was 14.9.6 h having a minimum of 12 and maximumof 20 h. Serum and CSF magnesiumlevelsweresignificantlyhigherinGroupMg.Duration of surgery have been 34.five.4 min in Group C and 39.90 min in GroupMg(p=0.054).Noneofthepatientsneededadditional intraoperative analgesia. Block traits and negative effects are presented in Table 2.TimetolossofcoldsensationatT4levelwassignificantly more quickly in the pre-eclamptic group in Bcl-xL Storage & Stability comparison with control. Medianmotorblocklevelsweresimilarinbothgroups;onlytwo patientsofGroupChadpartialmotorblockofthelowerextremities (Bromage score 2). Time for you to 1st analgesic request was statistically longer in Group Mg in comparison with Group C, withameandifferenceof108.6min(95 CI=81.6-135.7). Baseline, maximum and minimum SBP and HR values are presentedinFigure1.Haemodynamicdata,fluidandephedrine requirementsareshowninTable3.Baseline,maximumandminimumSBPvaluesweresignificantlyhigherinGroupMgthan in Group C. Fluid consumption was higher in Group C, whereas nosignificantdifferencewasobservedinhypotensionincidence. DISCUSSION ThisstudyhasdemonstratedforthefirsttimethatIVMgSO4 therapy in pre-eclamptic patients prolonged the time to first257.17.5 194.50.1 0.015 T3[T2-T4] T2.5[T1-T4] 0.162 3 [2-3] three [3-3] 0.162 99.12.7 1064.five 0.452 137.40.five 246.12.8 0.001 five(23.eight ) 6(30 ) 0.655 8(38.1 ) 8(40 ) 0.901 two(9.5 ) 1(5 ) 1 7(33.three ) 10(50 ) 0.Dataaregivenasmean D,median[min-max],number( ) p0.05:statisticalsignificancebetweenthegroups Evaluated using modified Bromage scaleTABLE 3.Numberofhypotensiveepisodes,fluidandephedrine requirement and number of patients requiring ephedrine Group C (n=21) Group Mg (n=20) pNumberofhypotensiveepisodes 2[0-5] 0[0-4] 0.06 Fluid(mL) 206066 1533870.001 Ephedrine(mg) 0[0-25] 0[0-20] 0.203 Numberofpatientsrequiringephedrine 10(47.six ) 5(25 ) 0.Dataaregivenasmedian[min-max]andnumber( ) p0.05:statisticalsignificancebetweenthegroupsanalgesic request when compared to healthier preterm parturients following spinal anaesthesia with bupivacaine and fentanyl.WealsoobservedthatIVMgSO4therapysignificantly accelerated the onset of sensory block. Magnesium can be a non-competitive NMDA-antagonist and can potentiate opioid activity with central desensitisation (18).ThereareafewstudieswhichhavelookedattheanalgesiceffectsofIVmagnesiuminpatientsundergoingspinal anaesthesia;even so,noneofthemhaveincludedanobstetric population(3-5).Inallofthesestudies,lowerdosesofMgSO4 (rangingfrom1.03gto12.35g)wereusedandtheinfusions have been started immediately after lumbar puncture. In contrast to these studies(3-5),inourstudy,pre-eclampticpatientsreceivedMgSO4 ahead of spinal anaesthesia plus the lowest total dose of magneBalkan Med J, Vol. 31, No. 2,Seyhan et al. Magnesium Therapy and Spinal Anaesthesia in Pre-eclampsiaGroup C SBP (mmHg) 180 160#Group Mg HR (beatmin)120 100 80 60 40 20 0 SBP BRD4 list Baseline SBP max SBP min HR baseli.
